- Business Partners
loosens mucus physically
Tacholiquin® or its active ingredient tyloxapol has been successfully administered via inhalation for more than 50 years.
Tacholiquin® 1% solution is intended for the adjunctive treatment of a variety of airways and lung disorders associated with the formation of viscous sputum:
- Pseudo-croup (viral laryngitis in conjunction with coughing and shortness of breath)
- Bronchial asthma
- Bronchiectasis (abnormal widening of the bronchi)
- Atelectases (non-ventilated parts of the lung due to partial collapse of the lung)
Tacholiquin® can also be used whenever the respiratory tract’s self-cleaning function is impaired:
Babies from 3 month, infants, small children as well as adults benefit from this very well-tolerated preparation with its purely physical mode of action which does not affect the physiological conditions at the mucosa.
Tacholiquin® is suitable for inhalation and instillation. Commercially available nebulisers (such as PARIboy) can be used for inhalation. Do not use hot-water boilers.
Tacholiquin® - overview of dosage forms and dosages.
All details on the exact application, dosage and ingredients are found on the linked package leaflet. These are in German. If you need detailed English information, please contact us.
Solution (only for clinic use)
Tacholiquin 10 x 5 ml
Tacholiquin® contains the active ingredient tyloxapol.
Tyloxapol is a surface-active wetting agent or surfactant and has a mucolytic effect.
Its purely physical effect results from three important components: